CXCR4 and neoplasm: In particular, the T1-weighted MR signal intensities in tumor site of anti-CXCR4-NaGdF4 NDs treated mice are stronger than those of Try-NaGdF4 NDs treated mice at all timed intervals within 12 h post-injection.